ArticleOphthalmology and therapy2026
Safety and Efficacy of Microhook Ab Interno Trabeculotomy Combined with Cataract Surgery in Older Patients with Glaucoma.
Article in Ophthalmology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionEvidence regarding minimally invasive glaucoma surgery in very old patients remains limited, making surgical decision-making challenging in this population. We investigated age-related differences in the safety and efficacy of microhook ab interno trabeculotomy combined with cataract surgery (combined µLOT).
methodsThis single-center retrospective study in Japan included 67 consecutive glaucomatous eyes of 67 patients who underwent combined µLOT and were followed for at least 6 months. The cohort comprised 27 male and 40 female patients. Patients were divided by median age into younger (< 76 years, n = 32) and older (≥ 76 years, n = 35) groups. Qualified success was defined irrespective of postoperative glaucoma medication use and without the need for additional glaucoma surgery, and was evaluated using three intraocular pressure (IOP) criteria: criterion A, 6 ≤ IOP ≤ 18 mmHg; criterion B, 6 ≤ IOP ≤ 15 mmHg; and criterion C, 6 ≤ IOP ≤ 13 mmHg.
resultsThe mean age of the older group was 82.5 years. At 6 months, qualified success probabilities were 94.0%, 82.1%, and 60.0% for criteria A, B, and C, respectively. Although the older group had higher qualified success under criterion C (71.4% vs. 46.9%; nominal P = 0.04) and lower IOP from week 2 to month 6, age was not independently associated with surgical failure in multivariable Cox analyses. Higher preoperative IOP, hypertension, and antithrombotic therapy showed exploratory associations with failure. Postoperative hyphema, transient IOP elevation, corneal endothelial cell loss, and systemic complications were not increased in the older group.
conclusionCombined µLOT provided favorable short-term IOP control without an increased complication burden in older patients, although baseline medication burden may have confounded the age-group comparison. These real-world findings provide clinically relevant evidence for surgical decision-making in very old patients and may be informative for other aging societies.
Indexed as
Identifiers
42909793What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.